Iradimed Co (IRMD) — Capital Reinvestment Ratio
Latest as of June 2026:
0.03x
Iradimed Co (IRMD) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($5.94 Million) in capital expenditures ($185.00K). Check IRMD tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$5.94 Million
USD
Capital Expenditures
$185.00K
USD
Data as of
Jun 2026
Most recent filing
Iradimed Co Capital Reinvestment Ratio (2012–2025)
This chart tracks Iradimed Co's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see IRMD cash generation efficiency.
Annual Capital Reinvestment Ratio for Iradimed Co (2012–2025)
Year-by-year Capital Reinvestment Ratio for Iradimed Co from 2012 to 2025. See Iradimed Co (IRMD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | $24.95 Million | $7.76 Million | ▼ -0.4% |
| 2024 | 0.31x | $25.62 Million | $8.01 Million | ▼ -47.5% |
| 2023 | 0.59x | $13.47 Million | $8.01 Million | ▲ +218.5% |
| 2022 | 0.19x | $10.04 Million | $1.87 Million | ▲ +183.4% |
| 2021 | 0.07x | $11.26 Million | $741.76K | ▼ -39.8% |
| 2020 | 0.11x | $5.82 Million | $636.75K | ▲ +130.5% |
| 2019 | 0.05x | $10.23 Million | $485.81K | ▲ +32.3% |
| 2018 | 0.04x | $7.38 Million | $264.67K | ▼ -85.1% |
| 2017 | 0.24x | $3.42 Million | $824.76K | ▲ +49.0% |
| 2016 | 0.16x | $9.41 Million | $1.52 Million | ▲ +293.7% |
| 2015 | 0.04x | $7.65 Million | $314.84K | ▼ -82.4% |
| 2014 | 0.23x | $2.59 Million | $606.29K | ▲ +80.3% |
| 2013 | 0.13x | $1.47 Million | $191.76K | ▲ +21.5% |
| 2012 | 0.11x | $1.51 Million | $161.56K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow